Aphanizomenon Flos-aquae extract effect on mobilization of bone marrow stem cells
Phase 3
- Conditions
- Type 2 Diabetes Mellitus.Diabetes Mellitus
- Registration Number
- IRCT201108074920N2
- Lead Sponsor
- Sabalan Talaee Asia Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with type 2 diabetes; between 20 to 60 years with HbA1C=7.5% will be included in the study.
Exclusion criteria are pregnancy; presence advanced diabetic complications; renal failure or cardiovascular disease; use of vitamin or mineral supplements in the last 2 months before the study; change or introduction of new medications to the treatment of diabetes, and a history of inflammatory illness or cancer.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stem cell marker of CD34. Timepoint: Before and After treatment (0 and 12 weeks). Method of measurement: Flocytometry method.
- Secondary Outcome Measures
Name Time Method